Engineered liposomes deliver antibacterial agents targeting bacterial membranes, suggesting a new approach to fight resistance.
The global rise of antibiotic resistance necessitates targeted antimicrobial strategies. Nanomaterials bypass bacterial defenses but suffer from limited targeting and non-specific interactions. We engineered light-responsive liposomes with D-alanine for bacterial...
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: